×
About 205 results

ALLMedicine™ Acneiform Eruptions Center

Research & Reviews  57 results

Skin reactions from melanoma targeted and immune therapies range from pruritus to SJS
https://www.mdedge.com/dermatology/article/261580/melanoma/skin-reactions-melanoma-targeted-and-immune-therapies-range
Doug Brunk

Mar 3rd, 2023 - SAN DIEGO – A downside of the revolutionary advances in targeted and immune therapies used to treat melanoma are their potential to trigger a wide range of skin reactions, from acneiform eruptions to Stevens-Johnson Syndrome (SJS). “These skin rea.

Spectrum of dermatologic adverse events associated with amivantamab use
https://www.mdedge.com/hematology-oncology/article/261095/melanoma/spectrum-dermatologic-adverse-events-associated
Walter Alexander

Feb 7th, 2023 - A case series of epidermal growth factor receptor (EGFR) exon 20 insertion–mutated advanced non–small cell lung cancer patients with dermatologic adverse events (dAEs) subsequent to treatment with amivantamab showed classic toxic effects associate.

Tumor necrosis factor-alpha inhibitors and acne fulminans: Friend or foe?
https://doi.org/10.1111/pde.15226
Pediatric Dermatology; Barry KK, Neale HD et. al.

Dec 28th, 2022 - Acne fulminans (AF) is an uncommon variant of inflammatory acne with abrupt eruption of painful nodules, pustules, and hemorrhagic ulcerations, often associated with systemic symptoms. Paradoxical adverse reactions to tumor necrosis (TNF)-alpha in...

Acneiform Eruption Following Elexacaftor-Tezacaftor-Ivacaftor Treatment in Patients Wit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713678
JAMA Dermatology; Okroglic L, Sohier P et. al.

Dec 1st, 2022 - A new treatment for cystic fibrosis combining 3 CFTR modulators-elexacaftor (ELX), tezacaftor (TEZ), and ivacaftor (IVA)-has recently been approved for cystic fibrosis treatment. The cutaneous adverse effects following treatment with this combinat...

Acneiform Eruptions
http://emedicine.medscape.com/article/1072536-overview

Oct 25th, 2022 - Practice Essentials Acneiform eruptions are dermatoses that resemble acne vulgaris. Lesions may be papulopustular, nodular, or cystic. While acne vulgaris typically consists of comedones, acneiform eruptions (such as acneiform drug eruptions) usua...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  2 results

Timolol for the Treatment of Acne and Rosacea
https://clinicaltrials.gov/ct2/show/NCT02774590

Nov 11th, 2021 - Rosacea affects roughly 16 million Americans who desire better treatments than those currently available. Acne vulgaris, another chronic inflammatory skin disorder, mainly affects teenagers but also affects 20-40% of adults. Investigating potentia...

Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI
https://clinicaltrials.gov/ct2/show/NCT04864717

Sep 8th, 2021 - Background and Study Aims: Tyrosine Kinase inhibitors (TKIs) have become standard of care in patients with EGFR mutations in non-small cell lung cancer and other EGFR-mutated cancers. However, TKIs are well-known to cause cutaneous adverse events,...

see more →

News  18 results

Skin reactions from melanoma targeted and immune therapies range from pruritus to SJS
https://www.mdedge.com/dermatology/article/261580/melanoma/skin-reactions-melanoma-targeted-and-immune-therapies-range
Doug Brunk

Mar 3rd, 2023 - SAN DIEGO – A downside of the revolutionary advances in targeted and immune therapies used to treat melanoma are their potential to trigger a wide range of skin reactions, from acneiform eruptions to Stevens-Johnson Syndrome (SJS). “These skin rea.

Spectrum of dermatologic adverse events associated with amivantamab use
https://www.mdedge.com/hematology-oncology/article/261095/melanoma/spectrum-dermatologic-adverse-events-associated
Walter Alexander

Feb 7th, 2023 - A case series of epidermal growth factor receptor (EGFR) exon 20 insertion–mutated advanced non–small cell lung cancer patients with dermatologic adverse events (dAEs) subsequent to treatment with amivantamab showed classic toxic effects associate.

Acneiform Eruptions More Severe With Targeted Therapy Combos
https://www.medscape.com/viewarticle/975030

Jun 3rd, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Acneiform eruptions in patients with colorectal cancer are more extensive and severe when targeted cancer therapie...

Treatment-Related Dermatologic AEs in Melanoma Require Careful Management
https://www.onclive.com/view/treatmentrelated-dermatologic-aes-in-melanoma-require-careful-management

Oct 6th, 2021 - Tracey Liebman, MD Optimal management of treatment-related dermatologic adverse events (AEs) in patients with melanoma is essential for proper care, according to Tracey Liebman, MD. For the patients who develop nonspecific rash, pruritus or itch...

Strategies to Minimize mTOR-Related Dermatologic Adverse Events
https://www.onclive.com/view/strategies-to-minimize-mtor-related-dermatologic-adverse-events

Dec 5th, 2020 - Mario E. Lacouture, MD Many patients being treated with mTOR inhibitors experience dermatologic-related adverse events. Dermatologic side effects can have a psychosocial effect on patients, by affecting areas of the body exposed to other peop...

see more →